Go Deep
Braveheart Bio, Inc.
Braveheart Bio, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -25,913 | -3.2 | -18.35 | 0.01 | 1,851.68 |
| Oct 2026 | -25,388 | -3.1 | -17.57 | 0.01 | 1,772.12 |
| Oct 2026 | -25,701 | -3.2 | -18.04 | 0.01 | 1,821.42 |
| Oct 2026 | -26,364 | -3.3 | -19.03 | 0.01 | 1,921.93 |
| Oct 2026 | -26,846 | -3.5 | -19.75 | 0.01 | 1,990.01 |
| Oct 2026 | -27,121 | -3.5 | -20.17 | 0.01 | 2,027.51 |
| Oct 2026 | -27,096 | -3.5 | -20.13 | 0.01 | 2,032.13 |
Braveheart Bio, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -14,988,000.0 | -14,280,000.0 | -381,000.0 | -99,000.0 |
| EPS | -0.3 | -0.3 | -0.0 | -0.0 |
Braveheart Bio, Inc. Revenue & Profit: Last 1 Year
| Line Item | Dec 2025 |
|---|---|
| Revenue | 0.0 |
| Net Profit | -66,052,000.0 |
| EPS | -5.3 |
Braveheart Bio, Inc. Balance Sheet
| Line Item | Dec 2025 |
|---|---|
| Total Assets | 89,350,000.0 |
| Total Liabilities | 155,222,000.0 |
| Total Equity | -65,872,000.0 |
Owes vs Owns
Braveheart Bio, Inc. owed $1.76 for every $1 it owned in Jun 2026, up from $1.74 in Dec 2025.
| Period | Jun 2026 | Dec 2025 |
|---|---|---|
| Owes vs Owns | 1.76× | 1.74× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Braveheart Bio, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 99.8%
How it's funded — Dec 2025
Payables 0.7%Other liabilities 99.3%
| Line Item | Dec 2025 |
|---|---|
| Assets | |
| Cash & short-term investments | 89.2 |
| Receivables | 0.0 |
| Inventory | 0.0 |
| Fixed assets (tangible) | 0.0 |
| Intangible assets | 0.0 |
| Long-term investments | 0.0 |
| Other assets | 0.2 |
| Liabilities & equity | |
| Short-term debt | 0.0 |
| Long-term debt | 0.0 |
| Payables | 1.1 |
| Other liabilities | 154.2 |
| Shareholders' equity | -65.9 |
| Net tangible assets | -65.9 |
Braveheart Bio, Inc. Cash Flow
| Line Item | Dec 2025 |
|---|---|
| Operating Activities | -2,014,000.0 |
| Investing Activities | -33,569,000.0 |
| Financing Activities | 124,744,000.0 |